SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study

BACKGROUND: Vaccines offer people with multiple sclerosis (PwMS) an effective protection against severe COVID-19 disease courses. However, representative real-world data on the tolerability of SARS-CoV-2 vaccines in PwMS are limited. We aimed at analysing vaccination reactions (VRs) and MS deteriora...

Descripción completa

Detalles Bibliográficos
Autores principales: Frahm, Niklas, Fneish, Firas, Ellenberger, David, Haas, Judith, Loebermann, Micha, Parciak, Tina, Peters, Melanie, Pöhlau, Dieter, Rodgers, Jeff, Röper, Anna-Lena, Schilling, Sarah, Stahmann, Alexander, Temmes, Herbert, Zettl, Uwe K., Middleton, Rodden M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438509/
https://www.ncbi.nlm.nih.gov/pubmed/36090519
http://dx.doi.org/10.1016/j.lanepe.2022.100502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438509/
https://www.ncbi.nlm.nih.gov/pubmed/36090519
http://dx.doi.org/10.1016/j.lanepe.2022.100502

Ejemplares similares